Cargando…
SerpinB3 drives cancer stem cell survival in glioblastoma
Despite therapeutic interventions for glioblastoma (GBM), cancer stem cells (CSCs) drive recurrence. The precise mechanisms underlying CSC resistance, namely inhibition of cell death, are unclear. We built on previous observations that the high cell surface expression of junctional adhesion molecule...
Autores principales: | Lauko, Adam, Volovetz, Josephine, Turaga, Soumya M., Bayik, Defne, Silver, Daniel J., Mitchell, Kelly, Mulkearns-Hubert, Erin E., Watson, Dionysios C., Desai, Kiran, Midha, Manav, Hao, Jing, McCortney, Kathleen, Steffens, Alicia, Naik, Ulhas, Ahluwalia, Manmeet S., Bao, Shideng, Horbinski, Craig, Yu, Jennifer S., Lathia, Justin D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513382/ https://www.ncbi.nlm.nih.gov/pubmed/36103817 http://dx.doi.org/10.1016/j.celrep.2022.111348 |
Ejemplares similares
-
OTEH-2. High-dimensional analysis of spatial immune cell heterogeneity in glioblastoma reveals differences between contrast-enhancing and non-contrast-enhancing tumor rims
por: Watson, Dionysios C, et al.
Publicado: (2021) -
IL-11 drives postsurgical hepatocellular carcinoma recurrence
por: Lauko, Adam, et al.
Publicado: (2019) -
IgM-Linked SerpinB3 and SerpinB4 in Sera of Patients with Chronic Liver Disease
por: Biasiolo, Alessandra, et al.
Publicado: (2012) -
Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition
por: Biasiolo, Alessandra, et al.
Publicado: (2023) -
Induction of SerpinB2 and Th1/Th2 Modulation by SerpinB2 during Lentiviral Infections In Vivo
por: Major, Lee D., et al.
Publicado: (2013)